Protocol Based-furosemide Stress Test Versus Standard Care to Evaluate Renal Recovery During Continuous Renal Replacement Therapy - Trial NCT06229990
Access comprehensive clinical trial information for NCT06229990 through Pure Global AI's free database. This Phase 4 trial is sponsored by Chiang Mai University and is currently Recruiting. The study focuses on Acute Kidney Injury. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Chiang Mai University
Timeline & Enrollment
Phase 4
Jan 01, 2024
Jun 07, 2024
Primary Outcome
% of patients with Renal recovery
Summary
Currently, continuous renal replacement therapy (CRRT) is the main modality for renal support
 in critically ill patients with hemodynamic instability. Most studies have investigated the
 timing of RRT initiation. However, prolonged CRRT demonstrated the association of many
 unexpected events, such as catheter-related complications, catheter-related blood stream
 infection, hypotension, hypothermia, tachycardia, and atrial fibrillation. Up to now, there
 is a lack of evidence regarding the timing of withholding CRRT. The furosemide stress test
 (FST) is a tool that is easy to use and has more availability. The investigators aimed to
 apply FST to evaluate renal recovery compared with standard treatment in critically ill
 patients undergoing CRRT.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06229990
Non-Device Trial